Sage Journals: Discover world-class research

Open access

Research article

First published 2021-1

Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia

Mengistu Bekele, Ole Frithjof Norheim, Alemayehu Hailu

MDM Policy & Practice

Open access

Case report

First published 2022

S.U.G.A.R: A Case to Outline Tactics for the Prevention of Alpelisib-Induced Hyperglycemia

Katharine Thomas, Monique Germain, Michelle M. Loch

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2022-3

Bullous Drug Reaction with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

K. Geetha, Puja

Journal of Pharmacology and Pharmacotherapeutics

Retricted access

Other

First published 2009-7

Results of the LEAD-2 study in relation to NICE and ADA/EASD guidelines for the treatment of type 2 diabetes in the UK

John Wilding

The British Journal of Diabetes & Vascular Disease

Open access

Research article

First published 2015-03

A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes

F. Javier Ampudia-Blasco, Pierre Yves Benhamou, Guillaume Charpentier [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2007-1

Effect of Metatarsal Pad Placement on Plantar Pressure in People with Diabetes Mellitus and Peripheral Neuropathy

Mary K. Hastings, Michael J. Mueller, Thomas K. Pilgram [...]

Foot & Ankle International

Free access

Review article

First published 2015-2

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus

Kira B. Harris, Delilah J. McCarty

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2001-07

Diabetics with Hypertension Not Controlled with ACE Inhibitors: Alternate Therapies

Ton J. Cleophas, Bas M. van Ouwerkerk, Jan van der Meulen [...]

Angiology

Retricted access

Review article

First published 2020-5

Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus

Kevin Cowart

Annals of Pharmacotherapy

Retricted access

Research article

First published 2015-7

Estimating Cost-Effectiveness in Type 2 Diabetes

Phil McEwan, Jason Gordon, Marc Evans [...]

Medical Decision Making

Search results